Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model

被引:9
|
作者
Wang, Lei [1 ,2 ]
Sun, Ximeng [2 ]
Huang, Jingjing [2 ]
Zhan, Bin [3 ]
Zhu, Xinping [2 ,4 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Beijing Trop Med Res Inst, Beijing, Peoples R China
[2] Capital Med Univ, Sch Basic Med Sci, Dept Med Microbiol & Parasitol, Beijing, Peoples R China
[3] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA
[4] Capital Med Univ, Res Ctr Microbiome, Beijing, Peoples R China
来源
基金
北京市自然科学基金; 中国国家自然科学基金;
关键词
Trichinella spiralis; vaccine; prime-boost; mucosal immunity; Salmonella typhimurium; HUMAN TRICHINOSIS; BALB/C MICE; STRATEGIES; EPIDEMIOLOGY; CHINA; CONSUMPTION; PARAMYOSIN; RESPONSES; VACCINES; PHASE;
D O I
10.3389/fmicb.2017.01394
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
TsPmy is a paramyosin expressed by parasitic Trichinella spiralis and confers a protective immunity when its recombinant protein or DNA was used as an immunogen. To improve its immunogenicity and vaccine efficacy, we conducted a heterologous prime-boost strategy by orally delivering one dose of TsPmy DNA carried by attenuated Salmonella typhimurium (SL7207), followed by two doses of recombinant TsPmy intramuscularly. This strategy effectively induced intestinal mucosal sIgA response and an enhanced and balanced Th1/Th2 immune responses that improve protection against T. spiralis larval challenge, with 55.4% muscle larvae reduction and 41.8% adult worm reduction compared to PBS control. The muscle larvae reduction induced by heterologous primeboost regimen was significant higher than that induced by the homologous DNA or protein prime-boost regimens, which could act as a practical prophylactic approach to prevent T. spiralis infection.
引用
下载
收藏
页数:10
相关论文
共 50 条
  • [21] Protective immunity against Trichinella spiralis infection induced by TsNd vaccine in mice
    Liu, Pei
    Cui, Jing
    Liu, Ruo Dan
    Wang, Min
    Jiang, Peng
    Liu, Li Na
    Long, Shao Rong
    Li, Ling Ge
    Zhang, Shuai Bing
    Zhang, Xin Zhuo
    Wang, Zhong Quan
    PARASITES & VECTORS, 2015, 8
  • [22] Heterologous prime-boost vaccination based on Polymorphic protein D protects against intravaginal Chlamydia trachomatis infection in mice
    Romina Cecilia Russi
    Diego Del Balzo
    Agustín Luján
    Ivana Gabriela Reidel
    María Inés García
    Carolina Veaute
    María Teresa Damiani
    Scientific Reports, 12
  • [23] Heterologous prime-boost vaccination based on Polymorphic protein D protects against intravaginal Chlamydia trachomatis infection in mice
    Cecilia Russi, Romina
    Del Balzo, Diego
    Lujan, Agustin
    Gabriela Reidel, Ivana
    Ines Garcia, Maria
    Veaute, Carolina
    Teresa Damiani, Maria
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Heterologous prime-boost vaccination programs against Newcastle disease virus genotype VII in chickens
    Sedeik, M. E.
    Awad, A. M.
    El-Shall, N. A.
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2022, 87
  • [25] Omicron Breakthrough Infection After Heterologous Prime-Boost Vaccination Induces a Vigorous Antibody Response
    Varese, Augusto
    Mazzitelli, Bianca
    Erra Diaz, Fernando
    Kjolhede, Maria Victoria
    Ojeda, Diego
    Vellicce, Alejandra
    Arto, Penelope
    Cicero, Carla
    Pascowski, Maria
    Figueras, Laura
    Broese, Barbara
    Davila, Rosa
    Zarlenga, Rocio
    Rivelli, Federico
    Verruno, Camila
    Silenzi, Valeria
    Beltran, Ivana
    Gamarnik, Andrea
    Ceballos, Ana
    Zala, Carlos
    Badolati, Adelina
    Geffner, Jorge
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (10): : 1717 - 1720
  • [26] Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    Ran He
    Xinxin Yang
    Cheng Liu
    Xiangyu Chen
    Lin Wang
    Minglu Xiao
    Jianqiang Ye
    Yuzhang Wu
    Lilin Ye
    Cellular & Molecular Immunology, 2018, 15 : 815 - 826
  • [27] Efficient control of chronic LCMV infection by CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    He, Ran
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [28] Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    He, Ran
    Yang, Xinxin
    Liu, Cheng
    Chen, Xiangyu
    Wang, Lin
    Xiao, Minglu
    Ye, Jianqiang
    Wu, Yuzhang
    Ye, Lilin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2018, 15 (09) : 815 - 826
  • [29] Efficient control of chronic LCMV infection by a CD4 T cell epitope-based heterologous prime-boost vaccination in a murine model
    Xie, L.
    He, R.
    Wang, Y.
    Luo, Y.
    Ye, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 394 - 395
  • [30] Heterologous prime-boost viral vector cancer vaccines have protective effects against a syngeneic mouse model of glioblastoma
    Steffke, Emily E.
    Noblecourt, Laurine
    Almeida, Vinnycius Pereira
    Wicki, Amanda
    McAuliffe, James
    Kohanbash, Gary
    Okada, Hideho
    Leung, Carol
    Terabe, Masaki
    Van den Eynde, Benoit
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):